Clinical trials
Observational Multiple Sclerosis trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
143 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 2 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 4 |
| 2012 | 3 |
| 2013 | 4 |
| 2014 | 4 |
| 2015 | 6 |
| 2016 | 5 |
| 2017 | 5 |
| 2018 | 14 |
| 2019 | 17 |
| 2020 | 16 |
| 2021 | 23 |
| 2022 | 13 |
| 2023 | 6 |
| 2024 | 13 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 143 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assiut University | 10 |
| University Hospital, Caen | 3 |
| Cantonal Hospital of St. Gallen | 2 |
| Central Hospital, Nancy, France | 2 |
| Charles University, Czech Republic | 2 |
| Dokuz Eylul University | 2 |
| Firat University | 2 |
| Groupe Hospitalier Pitie-Salpetriere | 2 |
| Hospices Civils de Lyon | 2 |
| Hospital Italiano de Buenos Aires | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis | 143 |
| Fatigue | 8 |
| Neuromyelitis Optica | 7 |
| Stroke | 7 |
| Multiple Sclerosis, Relapsing-Remitting | 6 |
| Parkinson Disease | 6 |
| Amyotrophic Lateral Sclerosis | 4 |
| Cognitive Dysfunction | 4 |
| Multiple Sclerosis, Chronic Progressive | 4 |
| Arthritis, Rheumatoid | 3 |
Trials
Showing 1 to 25 of 143. Each trial links to its page on Pharma Observatory.
43 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.